The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here's what we know.

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

Experts have expressed frustration over the lack of clear government messaging on what the public can expect from COVID ...

In a recent briefing document published by the United States Food and Drug Administration (US-FDA) ahead of an advisory ...

17, 2023 – On Twitter, as in real life, it’s a question on many minds: When should we think about the next COVID-19 ... view of how the FDA authorized the bivalent vaccine in September without ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

The Food and Drug Administration’s Vaccine Advisory Committee is meeting on Thursday to discuss the future of COVID-19 ...

The FDA hopes to simplify COVID-19 vaccine options to help cope with the continued presence and evolution of the virus.